DE60138385D1 - Heilmittel zur behandlung von erkrankungen des sehnervs - Google Patents

Heilmittel zur behandlung von erkrankungen des sehnervs

Info

Publication number
DE60138385D1
DE60138385D1 DE60138385T DE60138385T DE60138385D1 DE 60138385 D1 DE60138385 D1 DE 60138385D1 DE 60138385 T DE60138385 T DE 60138385T DE 60138385 T DE60138385 T DE 60138385T DE 60138385 D1 DE60138385 D1 DE 60138385D1
Authority
DE
Germany
Prior art keywords
diseases
treatment
sehnerv
remedies
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60138385T
Other languages
English (en)
Inventor
Tomiya Mano
Shunji Sogou
Eri Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEI Co Ltd
Original Assignee
MEI Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEI Co Ltd filed Critical MEI Co Ltd
Application granted granted Critical
Publication of DE60138385D1 publication Critical patent/DE60138385D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE60138385T 2000-06-29 2001-06-28 Heilmittel zur behandlung von erkrankungen des sehnervs Expired - Fee Related DE60138385D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000197250 2000-06-29
PCT/JP2001/005585 WO2002000260A1 (fr) 2000-06-29 2001-06-28 Jp0105585atif contre des maladies du nerf optique et analogue

Publications (1)

Publication Number Publication Date
DE60138385D1 true DE60138385D1 (de) 2009-05-28

Family

ID=18695597

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60138385T Expired - Fee Related DE60138385D1 (de) 2000-06-29 2001-06-28 Heilmittel zur behandlung von erkrankungen des sehnervs

Country Status (8)

Country Link
US (2) US20030109566A1 (de)
EP (1) EP1297849B1 (de)
JP (1) JPWO2002000260A1 (de)
AT (1) ATE428470T1 (de)
AU (1) AU2001267864A1 (de)
CA (1) CA2414586C (de)
DE (1) DE60138385D1 (de)
WO (1) WO2002000260A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100921199B1 (ko) * 2001-05-11 2009-10-13 미쓰비시 타나베 파마 코퍼레이션 안정하고 고농도인 피라졸론 유도체를 포함하는 주사제
ZA200408449B (en) 2002-05-17 2007-09-26 Othera Pharmaceuticals Inc Amelioration of the development of cataracts and other opthalmic diseases
ATE497764T1 (de) * 2002-11-05 2011-02-15 Lead Chem Co Ltd Perkutane absorptionszubereitungen mit 3-methyl-1-phenyl-2-pyrazolin-5-on
US7825134B2 (en) 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
JP2007527417A (ja) * 2003-11-20 2007-09-27 オセラ・フアーマシユーチカルズ・インコーポレーテツド 白内障、黄斑変性および他の眼疾患の改善
WO2007055312A1 (ja) * 2005-11-10 2007-05-18 Mitsubishi Tanabe Pharma Corporation ピラゾロン化合物含有水溶液が充填されたプラスチック容器
US8168670B2 (en) * 2007-11-21 2012-05-01 Teikoku Pharma Usa, Inc. Pyrazolone derivative emulsion formulations
JP5591720B2 (ja) 2009-01-29 2014-09-17 株式会社林原 抗神経変性疾患剤
JP2017222575A (ja) 2014-09-19 2017-12-21 田辺三菱製薬株式会社 眼科疾患予防治療剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3533662A1 (de) * 1984-09-20 1986-03-27 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kombination von 1-phenyl-4-alkylpyrazolidindion-3,5-derivaten mit einem starken reduktionsmittel fuer die herstellung eines topischen entzuendungshemmenden arzneimittels fuer augen
JPS62108814A (ja) 1985-11-07 1987-05-20 Mitsubishi Chem Ind Ltd 過酸化脂質生成抑制剤
JPS61263917A (ja) 1985-05-20 1986-11-21 Mitsubishi Yuka Yakuhin Kk 脳機能正常化剤
DK169672B1 (da) * 1985-05-20 1995-01-09 Mitsubishi Chem Ind Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater
FR2608045B1 (fr) 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome
JP2906512B2 (ja) * 1990-01-16 1999-06-21 三菱化学株式会社 抗潰瘍剤
WO1993000088A1 (de) * 1991-06-24 1993-01-07 Hoechst Aktiengesellschaft Verwendung von phenylpyrazolin-derivaten zur behandlung von erhöhtem augeninnendruck
TW325997B (en) * 1993-02-02 1998-02-01 Senju Pharma Co Pharmaceutical composition for preventing and treating retinal diseases
JPH0725765A (ja) * 1993-07-07 1995-01-27 Mitsubishi Chem Corp 眼疾患用薬剤
JPH09278652A (ja) * 1996-04-05 1997-10-28 Sumitomo Pharmaceut Co Ltd 網膜疾患治療剤
GB9701710D0 (en) * 1997-01-28 1997-03-19 Karobio Ab Mammalian protein
JPH10218771A (ja) * 1997-02-05 1998-08-18 Ishihara Sangyo Kaisha Ltd ピラゾロン系化合物またはその塩を含有する血小板由来血管内皮細胞増殖因子活性阻害剤

Also Published As

Publication number Publication date
US7638516B2 (en) 2009-12-29
JPWO2002000260A1 (ja) 2004-01-08
US20060247293A1 (en) 2006-11-02
CA2414586C (en) 2009-09-29
EP1297849A4 (de) 2006-10-18
EP1297849B1 (de) 2009-04-15
WO2002000260A1 (fr) 2002-01-03
EP1297849A1 (de) 2003-04-02
CA2414586A1 (en) 2002-12-30
ATE428470T1 (de) 2009-05-15
AU2001267864A1 (en) 2002-01-08
US20030109566A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
ATE426413T1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
DE60101265D1 (de) Behandlung von augenschmerzen
DE502005001828D1 (de) Verwendung von rotigotin zur behandlung und prävention des parkinson-plus-syndroms
BR0108175A (pt) Derivados de piperazina e piperidina para o tratamento ou a prevenção de danos neuronais
SE9803710D0 (sv) Use of certain drugs for treating nerve root injury
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
WO2004096216A3 (en) Use of a topical medicament comprising riluzole
EA200300560A1 (ru) Улучшенный способ лечения
CY1108983T1 (el) Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων
DE60130872D1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis
BR0113201A (pt) processo para tratar distúrbios neurodegenerativos da retina e da cabeça do nervo óptico
EA200601238A1 (ru) Медикаменты для профилактики и лечения бромидроза и для улучшения запаха тела
BR9915569A (pt) Método para o tratamento de doenças neovasculares oculares
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
BR0309611A (pt) ácidos aminoalcanofosfÈnicos substituìdos para o tratamento da dor neuropática, dos distúrbios afetivos e da atenção, da esquizofrenia, do zumbido no ouvido, da miopia e de outros distúrbios oculares.
HUP0300566A2 (hu) Galantamin alkalmazása az Alzheimer-kórral összefüggő neuropszichiátriai viselkedésformák terápiájában
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
EP1482922A4 (de) Mittel für die corneale oder intrastromale verabreichung zur behandlung oder prävention von erkrankungen des auges
DE60231994D1 (de) Mittel zur behandlung oder prävention allergischerg
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
BRPI0417549A (pt) miméticos de superóxido dismutase para o tratamento de lesão de nervo óptico e retinal
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee